These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1709701)

  • 21. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.
    Balachandran R; Thampatty P; Enrico A; Rinaldo C; Gupta P
    Virology; 1991 Jan; 180(1):229-38. PubMed ID: 1701946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7 cosignal potentiates apoptosis of uninfected CD4+ T lymphocytic cell lines primed by HIV envelope proteins.
    Coito C; Bomsel M
    AIDS Res Hum Retroviruses; 1999 Apr; 15(6):509-21. PubMed ID: 10221528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.
    Andeweg AC; Leeflang P; Osterhaus AD; Bosch ML
    J Virol; 1993 Jun; 67(6):3232-9. PubMed ID: 7684463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
    Lusso P; Cocchi F; Balotta C; Markham PD; Louie A; Farci P; Pal R; Gallo RC; Reitz MS
    J Virol; 1995 Jun; 69(6):3712-20. PubMed ID: 7745720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro.
    Busso M; Thornthwaite J; Resnick L
    AIDS; 1991 Dec; 5(12):1425-32. PubMed ID: 1687645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.
    Barbeau B; Fortin JF; Genois N; Tremblay MJ
    J Virol; 1998 Sep; 72(9):7125-36. PubMed ID: 9696806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein.
    Freed EO; Myers DJ
    J Virol; 1992 Sep; 66(9):5472-8. PubMed ID: 1501283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.
    Mondor I; Ugolini S; Sattentau QJ
    J Virol; 1998 May; 72(5):3623-34. PubMed ID: 9557643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purified GPI-anchored CD4DAF as a receptor for HIV-mediated gene transfer.
    Brodsky RA; Jane SM; Vanin EF; Mitsuya H; Peters TR; Shimada T; Medof ME; Nienhuis AW
    Hum Gene Ther; 1994 Oct; 5(10):1231-9. PubMed ID: 7531502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope.
    Tschachler E; Buchow H; Gallo RC; Reitz MS
    J Virol; 1990 May; 64(5):2250-9. PubMed ID: 2182910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An internally positioned signal can direct attachment of a glycophospholipid membrane anchor.
    Caras IW
    J Cell Biol; 1991 Apr; 113(1):77-85. PubMed ID: 1706725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor.
    Liang X; Tang M; Zamb TJ; Babiuk LA; Kowalski J; Tykocinski ML
    J Virol; 1993 Aug; 67(8):4896-904. PubMed ID: 7687305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.
    Nagy G; Ward J; Mosser DD; Koncz A; Gergely P; Stancato C; Qian Y; Fernandez D; Niland B; Grossman CE; Telarico T; Banki K; Perl A
    J Biol Chem; 2006 Nov; 281(45):34574-91. PubMed ID: 16935861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.
    Sullivan N; Thali M; Furman C; Ho DD; Sodroski J
    J Virol; 1993 Jun; 67(6):3674-9. PubMed ID: 8497077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine.
    Ojwang J; Elbaggari A; Marshall HB; Jayaraman K; McGrath MS; Rando RF
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):560-70. PubMed ID: 7513761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.